Cancer Hospital of Guizhou Province
21
3
5
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 21 trials
100.0%
+13.5% vs industry average
52%
11 trials in Phase 3/4
33%
1 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (21)
The Efficacy of Lymph Node Dissection for Stage IIICr of Cervical Cancer(CQGOG0103)
Role: collaborator
Phase III Trial of Concurrent Chemotherapy Alone in Patients With Low-risk Nasopharyngeal Carcinoma
Role: collaborator
Neoadjuvant and Adjuvant Tislelizumab for Nasopharyngeal Carcinoma
Role: collaborator
A Study of Total Neoadjuvant Therapy for High-risk Locally Advanced Rectal Cancer
Role: collaborator
Effect of Standard Nutrition Therapy on Nutritional Status and Prognosis in Locoregionally Advanced Nasopharyngeal Carcinoma Patients With Malnutrition
Role: collaborator
Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection (Lipodox®) in Chinese Patients
Role: collaborator
A Non-interventional Registry Study of Fluzoparib in the Treatment of Ovarian Cancer
Role: collaborator
Effect of Chemoradiotherapy on Nutritional Status in Advanced NPC Patients
Role: collaborator
The Optimal Intervention Time of Radiotherapy for Oligometastatic Stage IV Non-small Cell Lung Cancer（NSCLC）
Role: collaborator
Efficacy of HIPEC in the Treatment of Advanced-Stage Epithelial Ovarian Cancer After Cytoreductive Surgery
Role: collaborator
Single-agent Capecitabine as Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
Role: collaborator
The Children and Adolescents Nasopharyngeal Carcinoma Survivor Study
Role: collaborator
Nedaplatin Versus Cisplatin and Capecitabine Versus Fluorouracil in IC + CCRT for Locoregionally Advanced NPC
Role: collaborator
Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
Role: collaborator
Chinese TaTME Registry Collaborative
Role: collaborator
Efficacy of HIPEC as NACT and Postoperative Chemotherapy in the Treatment of Advanced-Stage Epithelial Ovarian Cancer
Role: collaborator
Post-Marketing Surveillance of the Tanreqing Injection: a Real World Study
Role: collaborator
Adjuvant Treatment of Concurrent RT and CAPOX or Capecitabine Alone for Stage II and III Rectal Cancer
Role: collaborator
Treatment of Natural Killer/T Cell Lymphoma-I/II
Role: collaborator
Treatment of Natural Killer/T Cell Lymphoma-Ⅲ/Ⅳ
Role: collaborator